Expert Outlook: Align Tech Through The Eyes Of 5 Analysts
Portfolio Pulse from Benzinga Insights
Five analysts have recently updated their ratings on Align Technology (NASDAQ:ALGN), with a mix of bullish, indifferent, and bearish perspectives. The average 12-month price target for ALGN has been raised to $265.4, up 15.9% from the previous $229.00. Analysts from firms including Leerink Partners, Goldman Sachs, Piper Sandler, and UBS have adjusted their price targets and ratings, reflecting a nuanced view of the company's prospects. Align Technology, known for its Invisalign product, dominates the clear aligner market and has shown strong financial health indicators despite a slight revenue decline.
February 26, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Align Technology has received mixed analyst ratings with an updated average 12-month price target of $265.4, indicating a positive sentiment shift. The company's strong market presence and financial health metrics, despite a slight revenue decline, suggest resilience.
The updated analyst ratings and increased price target for ALGN reflect a positive sentiment shift among financial experts, despite a slight revenue decline. The company's strong market presence, superior financial health indicators, and dominance in the clear aligner market through its Invisalign product contribute to a positive outlook. The mixed ratings from analysts suggest a nuanced view, but the overall increase in the average price target indicates confidence in the company's future performance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100